glp-1 bacteria Gut microbiota and | Reviews in Endocrine and Metabolic Disorders GLP-1 agonists may reshape the

Description

SGLT2 Inhibitors and Ketone Metabolism in Heart Failure

Medical Disclaimer & Refund Policy

If you have a history of eating disorders, you are entitled to a referral to both an eating disorders specialist and an obesity medicine specialist ( Mozaffarian et al., Am J Clinical Nutrition, 2025 )

A new systematic review published in the journal eClinicalMedicine on Wednesday examined 48 studies that analyzed and predicted the outcomes of people who either had diabetes or were overweight or obese and took popular GLP-1 medications such as liraglutide (under brand names such as Victoza and Saxenda), semaglutide (under brand names such as Ozempic, Wegovy, Rybelsus) and tirzepatide (under brand names like Mounjaro and Zepbound)